FHI Earnings

FHI reported its earnings on 2026-01-29, showcasing a revenue of 482.83M against an estimate of 471.09M, resulting in a 2.49% surprise. The EPS was 1.39, surpassing the expected 1.2 by 15.83% . The stock experienced a 0.47% price change on the earnings day and a 0.25% change over the next five days, reflecting market reactions to the results.

Following FHI's earnings announcement on 2026-01-29, the stock price moved by 0.47% on the day of the release. Over the subsequent five days, it saw a 0.25% change. Historically, FHI's stock price tends to shift by an average of -0.22% in the 10 days leading up to earnings and +2.43% in the 10 days following, providing insight into potential market.

For 2026/Q1, analysts estimate FHI’s annual revenue to reach 466.08M, while the EPS is projected at 1.19. These estimates reflect recent revisions, with revenue estimates revised Revenue No Change by -0% and EPS estimates Revise Upward by 0.39% over the past three months, indicating analyst expectation in the company’s performance.

The correlation between FHI's stock price and earnings forecast revisions shows that positive revisions in revenue or EPS often strengthen the stock’s fundamentals. Over the past three months, revenue estimates for FY2025 were No Change by -0%, while EPS estimates moved Revise Upward by 0.39% . This trend suggests that price dips could present buying opportunities for investors.

Based on historical trends, FHI's stock price typically moves by -0.22% in the 10 days before its earnings and +2.43% in the 10 days after. For the upcoming 2026/Q1 earnings, analysts expect an EPS of 1.19 and revenue of 466.08M.

The earnings call presents a generally positive outlook with strong equity fund sales, strategic acquisitions, and innovative product developments like tokenized money market funds. Despite increased expenses and distribution costs, the company maintains positive operating leverage and plans for expansion. The Q&A highlighted effective succession planning, robust demand for MDT strategies, and promising collaborations with BNY Mellon and Goldman Sachs. While tokenization demand is slower than expected, the company's strategic initiatives and optimistic guidance suggest a positive stock price movement over the next two weeks.